All In Biotech

Drug Trial Radar · NCT04789330

Norepinephrine vs Phenylephrine During General Anesthesia

The Choice of Vasopressor for Treating Hypotension During General Anesthesia: a Pilot Pragmatic Cluster Cross-over Randomized Trial (the VEGA-1 Trial)

Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 3,626 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,626

Actual

Start

Jul 1, 2021

Primary completion

Apr 1, 2022

Study completion Apr 1, 2022

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 9, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

50 million patients undergo surgery each year in the United States. Postoperative mortality is considered the third leading cause of death worldwide. Hypotension during surgery have been linked to increased postoperative morbidity and mortality. Episodes of hypotension during surgery are associated with an increased risk of acute kidney injury, stroke, cardiac events and death. Treating or preventing hypotension during general anesthesia and major surgery was found to improve outcomes. At this time, it is unclear what is the best vasopressor to maintain blood pressure during surgery under general anesthesia. With this pilot pragmatic trial, the investigators will explore the impact of norepinephrine (NE) or phenylephrine (PE) on post-operative events in patients undergoing major surgery with general anesthesia and needing vasopressors infusion to maintain their systemic arterial pressure.

Conditions

  • Anesthesia
  • Surgery
  • Hypotension

Interventions

  • NorepinephrineDrug

    Norepinephrine administered during anesthesia

  • PhenylephrineDrug

    Phenylephrine administered during anesthesia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Assigned Vasopressor GivenTime frame: Anesthesia time, up to 24 hours

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • Zuckerberg San Francisco General Hospital

    San Francisco, California

  • UCSF Medical Center at Mount Zion

    San Francisco, California

  • UCSF Medical Center at Parnassus

    San Francisco, California

  • UCSF Medical Center at Mission Bay

    San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.